A novel mutation in SPART gene causes a severe neurodevelopmental delay due to mitochondrial dysfunction with complex I impairments and altered pyruvate metabolism
Open Access
- 7 August 2019
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 33 (10) , 11284-11302
Abstract
Loss‐of‐function mutations in the SPART gene cause Troyer syndrome, a recessive form of spastic paraplegia resulting in muscle weakness, short stature, and cognitive defects. SPART encodes for Spartin, a protein linked to endosomal trafficking and mitochondrial membrane potential maintenance. Here, we identified with whole exorne sequencing (WES) a novel frameshift mutation in the SPART gene in 2 brothers presenting an uncharacterized developmental delay and short stature. Functional characterization in an SH‐SY5Y cell model shows that this mutation is associated with increased neurite outgrowth. These cells also show a marked decrease in mitochondrial complex I (NADH dehydrogenase) activity, coupled to decreased ATP synthesis and defective mitochondrial membrane potential. The cells also presented an increase in reactive oxygen species, extracellular pyruvate, and NADH levels, consistent with impaired complex I activity. In concordance with a severe mitochondrial failure, Spartin loss also led to an altered intracellular Ca 2+ homeostasis that was restored after transient expression of wild‐type Spartin. Our data provide for the first time a thorough assessment of Spartin loss effects, including impaired complex I activity coupled to increased extracellular pyruvate. In summary, through a WES study we assign a diagnosis of Troyer syndrome to otherwise undiagnosed patients, and by functional characterization we show that the novel mutation in SPART leads to a profound bioenergetic imbalance.—Diquigiovanni, C., Bergamini, C., Diaz, R., Liparulo, I., Bianco, F., Masin, L., Baldassarro, V. A., Rizzardi, N., Tranchina, A., Buscherini, F., Wischmeijer, A., Pippucci, T., Scarano, E., Cordelli, D. M., Fato, R., Seri, M., Paracchini, S., Bonora, E. A novel mutation in SPART gene causes a severe neurodevelopmental delay due to mitochondrial dysfunction with complex I impairments and altered pyruvate metabolism. FASEB J. 33, 11284–11302 (2019). www.fasebj.orgKeywords
Funding Information
- Fondazione Telethon (GGP15171)
- Associazione Italiana per la Ricerca sul Cancro (IG_17069)
- Royal Society (RG110387)
This publication has 61 references indexed in Scilit:
- SPG20 Protein Spartin Is Recruited to Midbodies by ESCRT-III Protein Ist1 and Participates in CytokinesisMolecular Biology of the Cell, 2010
- Mitochondria and NeuroplasticityASN Neuro, 2010
- Developmental and degenerative features in a complicated spastic paraplegiaAnnals of Neurology, 2010
- Abnormal mitochondrial dynamics and neurodegenerative diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Endogenous spartin (SPG20) is recruited to endosomes and lipid droplets and interacts with the ubiquitin E3 ligases AIP4 and AIP5Biochemical Journal, 2009
- Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial FissionJournal of Biological Chemistry, 2009
- A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnoverJournal of Cell Biology, 2009
- Troyer Syndrome Protein Spartin Is Mono-Ubiquitinated and Functions in EGF Receptor TraffickingMolecular Biology of the Cell, 2007
- The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expressionMolecular Oncology, 2007
- Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channelsJournal of Cell Biology, 2006